CE vs CTOR · rev $10.28B vs $105.2M cap
Celanese Corporation (CE) versus Citius Oncology, Inc. (CTOR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
CTOR does not have a complete income-statement cache yet.
CE currently screens at market cap $5.92B. CTOR currently screens at market cap $105.2M.
Not investment advice. Open the CE and CTOR stock pages for the full models.
Not investment advice.